Upgrade to SI Premium - Free Trial

Novavax (NVAX) Reports Commencement of Phase 2 Clinical Trial of NanoFlu in Older Adults

September 25, 2018 7:04 AM
Novavax, Inc. (NASDAQ: NVAX) today announced the initiation of a Phase 2 dose and formulation confirmation clinical trial in older ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA Management Comments

Next Articles